Showing 2,301 - 2,320 results of 2,945 for search '"hepatitis"', query time: 0.05s Refine Results
  1. 2301

    A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Interv... by Laura R Saslow, Jamie Krinock, Alison O'Brien, Kaitlyn Raymond, Hovig Bayandorian, Judith T Moskowitz, Jennifer Daubenmier, Antonino Oliveri, Deanna J Marriott, Dina H Griauzde, Elizabeth K Speliotes

    Published 2025-01-01
    “…Across participants with a 4-month hepatic liver fat percent measurement, the percent change in liver fat was −33.17% (95% CI −86.48 to 20.14), and in only the participants who were adherent to the eating pattern, the percent change in liver fat was −53.12% (95% CI −71.25 to −34.99). …”
    Get full text
    Article
  2. 2302

    Case report: A study on the pathological diagnosis of oral fibrosarcoma in a giant panda by Zongliang Xiong, Shanshan Ling, Caiwu Li, Linhua Deng, Ming He, Chengdong Wang, Desheng Li, Zhengli Chen

    Published 2025-02-01
    “…Hematological tests revealed elevated levels of the tumor marker CA724, along with infectious disease, anemia, hepatic damage, and renal failure. Imaging studies identified a soft tissue mass in the right cheek area. …”
    Get full text
    Article
  3. 2303
  4. 2304

    Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives by Siyuan Yang, Yunyi Zou, Chunhua Zhong, Zuoqiong Zhou, Xiyang Peng, Changfa Tang

    Published 2025-01-01
    “…Conversely, excessive pyroptosis intensifies inflammatory responses, exacerbates hepatocyte damage and promotes the activation and proliferation of hepatic stellate cells, accelerating liver fibrosis. …”
    Get full text
    Article
  5. 2305

    Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse by Maha Elsabaawy, Omkosoum Alhaddad

    Published 2024-03-01
    “…The lack of disease-specific nutritional guidance, the prevalent sedentary lifestyle among patients, and insufficient screening for hepatocellular carcinoma, oesophageal varices, sarcopaenia, minimal hepatic encephalopathy, and diabetes mellitus, along with fibrosis progression and cirrhosis decompensation, can add further complexities. …”
    Get full text
    Article
  6. 2306

    The Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation by Joshua Santos, Philip Young, Igor Barjaktarevic, Catherine Lazar, Irawan Susanto, Tisha Wang

    Published 2014-01-01
    “…Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and subsequent hypoxemia in the setting of hepatic dysfunction. There is currently no pharmacologic intervention that has been shown to significantly affect outcomes and liver transplantation remains the mainstay of therapy. …”
    Get full text
    Article
  7. 2307

    Raoultella Planticola Bacteremia Following Consumption of Seafood by Philip W Lam, Irving E Salit

    Published 2014-01-01
    “…Recent chemotherapy, proton pump inhibitor use and altered biliary flow secondary to hepatic metastases may have been contributing factors to the pathogenesis of disease.…”
    Get full text
    Article
  8. 2308

    Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis by Stefania Bruno, Maria Beatriz Herrera Sanchez, Chiara Pasquino, Marta Tapparo, Massimo Cedrino, Ciro Tetta, Giovanni Camussi

    Published 2019-01-01
    “…In addition, HLSCs show a specific commitment to the hepatic phenotype. Injection of HLSCs into immunodeficient mice fed with a methionine-choline-deficient diet to induce nonalcoholic steatohepatitis ameliorates liver function and morphology. …”
    Get full text
    Article
  9. 2309

    Is There a Role for Probiotics in Liver Disease? by Robert S. Lo, Andrew S. Austin, Jan G. Freeman

    Published 2014-01-01
    “…There is mounting evidence that probiotics are effective in the treatment of covert and overt hepatic encephalopathy, as well as in the prevention of recurrence of encephalopathy. …”
    Get full text
    Article
  10. 2310

    Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis by D. V. Garbuzenko

    Published 2012-04-01
    “…Gastroduodenoscopy and hepatic venous pressure gradient measurement remain to be the standard methods of screening diagnostics of patients with liver cirrhosis for estimation of VEV bleeding risk nowadays. …”
    Get full text
    Article
  11. 2311
  12. 2312

    FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER by D. V. Sidorov, S. O. Stepanov, M. V. Lozhkin, L. O. Petrov, O. V. Gutz, A. A. Kostin, A. G. Isaeva

    Published 2017-09-01
    “…In patients with a reduced functional reserve of the liver or a missing volume of the remaining liver parenchyma, these interventions become impossible because of the increased risk of postresectional acute hepatic insufficiency. One of the most modern and promising ways to overcome this obstacle is the use of minimally invasive methods of tumor destruction. …”
    Get full text
    Article
  13. 2313

    Systemic and Local CC Chemokines Production in a Murine Model of Listeria monocytogenes Infection by Marina Bubonja, Branka Wraber, Gordana Brumini, Ivana Gobin, Danijela Veljkovic, Maja Abram

    Published 2006-01-01
    “…Repeated intragastric inoculation of Listeria monocytogenes into BALB/c mice resulted in prolonged bacteraemia and severe hepatic infection. Bacteria could also be isolated from the brain tissue of all experimental mice. …”
    Get full text
    Article
  14. 2314

    Transdermal patches: Design and current approaches to painless drug delivery by Al Hanbali Othman A., Khan Haji Muhammad Shoaib, Sarfraz Muhammad, Arafat Mosab, Ijaz Shakeel, Hameed Abdul

    Published 2019-06-01
    “…Use of transdermal patches can evade many issues associated with oral drug delivery, such as first-pass hepatic metabolism, enzymatic digestion attack, drug hydrolysis and degradation in acidic media, drug fluctuations, and gastrointestinal irritation. …”
    Get full text
    Article
  15. 2315

    Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease by Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi, David A. Brenner

    Published 2010-01-01
    “…Upon stimulation by these TLR ligands, hepatic immune cells produce various mediators that are involved in host defense. …”
    Get full text
    Article
  16. 2316

    Atypical Presentation of Cat-Scratch Disease in an Immunocompetent Child with Serological and Pathological Evidence by Serkan Atıcı, Eda Kepenekli Kadayıfcı, Ayşe Karaaslan, Muhammed Hasan Toper, Cigdem Ataizi Celikel, Ahmet Soysal, Mustafa Bakır

    Published 2014-01-01
    “…Herein we present a case of systemic CSD presenting with hepatic mass in an immunocompetent child. The differential diagnosis is made by serological and pathological evidence. …”
    Get full text
    Article
  17. 2317

    Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease by Yu-Hong Fan, Siyao Zhang, Ye Wang, Hongni Wang, Hongliang Li, Hongliang Li, Hongliang Li, Lan Bai

    Published 2025-01-01
    “…This disease is closely associated with metabolic disorders driven by overnutrition, with key pathological processes including lipid dysregulation, impaired lipid autophagy, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and local inflammation. While hepatic lipid metabolism in NAFLD is well-documented, further research into inter-organ communication mechanisms is crucial for a deeper understanding of NAFLD progression. …”
    Get full text
    Article
  18. 2318
  19. 2319

    Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer by Lulu Sun, Chunmei Liang, Yuqin Wang, Hui Li, Lijun Yao, Huajun Jiang

    Published 2024-12-01
    “…We present a case of a 68-year-old male patient with ESRD who experienced various decompensated complications of liver cirrhosis, particularly massive ascites and hepatic space-occupying lesions. Peritoneal dialysis (PD) catheter insertion and continuous ambulatory peritoneal dialysis (CAPD) treatment were successfully performed. …”
    Get full text
    Article
  20. 2320

    Case Report of Probable DRESS Syndrome Associated with Ribociclib by Florian Carneiro, Marine Bove, Frédérique Beau-Salinas, Tevy San, Pierre Combe

    Published 2023-01-01
    “…Here, we present the case of an 83-year-old patient who developed a probable DRESS syndrome induced by ribociclib, presenting with fever, eosinophilia, rash, and hepatic cytolysis. The RegiSCAR score was 4. The symptomatology evolved favorably with topical and systemic corticosteroids, without any sequel. …”
    Get full text
    Article